Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

254 ARTÍCULOS , VIENDO DEL 241 AL 254

Non-REM sleep with hypertonia in Parkinsonian Spectrum Disorders: A pilot investigation

Levendowski DJ, Walsh CM, Boeve BF, Tsuang D, Hamilton JM, Salat D, Berka C, Lee-Iannotti JK, Shprecher D, Westbrook PR, Mazeika G, Yack L, Payne S, Timm PC, Neylan TC, St Louis EK.

Sleep Med. 2022 Dec;100:501-510. doi: 10.1016/j.sleep.2022.09.025. Epub 2022 Oct 4.

Repurposing SGLT2 Inhibitors for Neurological Disorders: A Focus on the Autism Spectrum Disorder

Nakhal MM, Aburuz S, Sadek B, Akour A.

Molecules. 2022 Oct 23;27(21):7174. doi: 10.3390/molecules27217174.

Could VGF and/or its derived peptide act as biomarkers for the diagnosis of neurodegenerative diseases: A systematic review

Alqarni S, Alsebai M.

Front Endocrinol (Lausanne). 2022 Dec 22;13:1032192. doi: 10.3389/fendo.2022.1032192. eCollection 2022.

Role of Long Non-coding RNAs in the Pathogenesis of Alzheimer's and Parkinson's Diseases

Sivagurunathan N, Ambatt ATS, Calivarathan L.

Curr Aging Sci. 2022;15(2):84-96. doi: 10.2174/1874609815666220126095847.

Salivary biomarkers of neurodegenerative and demyelinating diseases and biosensors for their detection

Goldoni R, Dolci C, Boccalari E, Inchingolo F, Paghi A, Strambini L, Galimberti D, Tartaglia GM.

Ageing Res Rev. 2022 Apr;76:101587. doi: 10.1016/j.arr.2022.101587. Epub 2022 Feb 11.

The many facets of CD26/dipeptidyl peptidase 4 and its inhibitors in disorders of the CNS - a critical overview

Bernstein HG, Keilhoff G, Dobrowolny H, Steiner J.

Rev Neurosci. 2022 Jul 1;34(1):1-24. doi: 10.1515/revneuro-2022-0026. Print 2023 Jan 27.

The Key Role of Magnetic Resonance Imaging in the Detection of Neurodegenerative Diseases-Associated Biomarkers: A Review

Li KR, Wu AG, Tang Y, He XP, Yu CL, Wu JM, Hu GQ, Yu L.

Mol Neurobiol. 2022 Oct;59(10):5935-5954. doi: 10.1007/s12035-022-02944-x. Epub 2022 Jul 12.

Extracellular vesicles, from the pathogenesis to the therapy of neurodegenerative diseases

Xia X, Wang Y, Zheng JC.

Transl Neurodegener. 2022 Dec 12;11(1):53. doi: 10.1186/s40035-022-00330-0.

Emerging urinary alpha-synuclein and miRNA biomarkers in Parkinson's disease

Giri B, Seamon M, Banerjee A, Chauhan S, Purohit S, Morgan J, Baban B, Wakade C.

Metab Brain Dis. 2022 Aug;37(6):1687-1696. doi: 10.1007/s11011-021-00735-2. Epub 2021 Apr 21.

Multimodal retinal imaging to detect and understand Alzheimer's and Parkinson's disease

Moons L, De Groef L.

Curr Opin Neurobiol. 2022 Feb;72:1-7. doi: 10.1016/j.conb.2021.07.007. Epub 2021 Aug 14.

Lewy Body Dementias: Controversies and Drug Development

Chiu SY, Bowers D, Armstrong MJ.

Neurotherapeutics. 2022 Jan;19(1):55-67. doi: 10.1007/s13311-021-01161-z. Epub 2021 Dec 2.

Biosensor approaches on the diagnosis of neurodegenerative diseases: Sensing the past to the future

Karaboğa MNS, Sezgintürk MK.

J Pharm Biomed Anal. 2022 Feb 5;209:114479. doi: 10.1016/j.jpba.2021.114479. Epub 2021 Nov 24.

Retinal imaging biomarkers of neurodegenerative diseases

Christinaki E, Kulenovic H, Hadoux X, Baldassini N, Van Eijgen J, De Groef L, Stalmans I, van Wijngaarden P.

Clin Exp Optom. 2022 Mar;105(2):194-204. doi: 10.1080/08164622.2021.1984179. Epub 2021 Nov 9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias